Nebular

Nebular, also referenced as Nebular Venture Capital, is a venture firm with a website, LinkedIn, and Crunchbase footprint consistent with a small or emerging European manager, plausibly with a deeptech, AI, or frontier-technology orientation given the cosmic naming convention. Without disclosed thesis, sector focus, or check-size data, the most honest read is a thesis-driven emerging fund rather than an institutional generalist. Healthcare exposure is plausibly selective rather than central, with potential interest in AI-for-biology, scientific computing, and frontier-tech-adjacent healthcare categories rather than mainstream digital health. AI focus is plausibly central given positioning. Anchoring to emerging-manager norms, expect pre-seed and seed checks plausibly in the EUR 100K to EUR 750K range, often co-investing with deeptech-friendly seed funds. This is the wrong door for healthcare services, hospital enterprise software, or therapeutics development where mainstream clinical and regulatory expertise is the unlock. It is a possible fit for technically ambitious early teams in AI-for-science and frontier-health categories that benefit from a thesis-aligned partner. Entry path is the website contact and LinkedIn outreach; warm introductions through deeptech investor networks raise reply rates materially. Founders should arrive with rigorous technical detail and a clear scientific or engineering bet; thesis-resonant pitches without technical depth will not advance with a frontier-oriented manager.